Bristol Myers Squibb Company
$BMY
Public valuation for Bristol Myers Squibb Company (BMY). Fair value, signal, and key metrics — no sign-in required.
Current Price
$66.81
27% Undervalued
Fair Value Estimate
$85
💎
Value
Established company trading at a low multiple
Analyst Consensus
Target: $66.21
1% lower than current
Key Metrics
Market Cap
$136.5B
Forward P/E
9.7x
Operating Margin
31.0%
Revenue Growth
3.2%
Get free watchlist alerts
Join the waitlist for valuation updates on $BMY and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.